The FDA announced on July 30, 2013, that West-Ward Pharmaceutical Corp. voluntarily recalled Lisinopril Tablets USP 2.5 mg due to failed impurity specifications. The recall affects specific lots of the drug distributed nationwide.
How to tell if you have it
- Brand: West-Ward Pharmaceutical
- Product: Lisinopril Tablets USP 2.5 mg
- NDC 0143-1265-01 (100-count bottles)
- NDC 0143-1265-10 (1000-count bottles)
- NDC 24658-240-10 (1000-count bottles manufactured for Blu Pharmaceuticals)
- Lots: 68679A, 68679C, Exp 01/15; 64456A, Exp 04/15; 68980A, Exp 05/15; 69234A, 69235A, Exp 07/15; 69607A, Exp 11/15; 69609C, 69835A, Exp 01/16; 64455B, Exp 08/13; 64456C, Exp 04/14; 64457A, Exp 10/14; 68679B, 68680A, Exp 01/15; 68980B, Exp 05/15; 69607B, 69608A, Exp 11/15; 69609B, Exp 01/16; 64455A, 64455C, 64455D, Exp 08/13; 64456B, Exp 04/14; 64457B, Exp 10/14; 68680B, Exp 01/15; 68980C, 68981A, Exp 05/15; 69608B, Exp 11/15; 69609A, Exp 01/16; 70169A, Exp 05/16
The hazard
GovInfoNow's records show the hazard involves out-of-specification results for individual other unknown related compounds at the 48-month time point. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include West-Ward Fentanyl Citrate Recall (May 13, 2015), VersaPharm Ethambutol Recall (Oct. 2, 2014), and West-Ward Isoniazid 300mg Recall (May 20, 2014). Other recent recalls of similar products include Rising Pharma Recalls Temozolomide 5mg Capsules Due to Impurity Issues (March 3, 2026), Inventia Chlorthalidone Recall (Sept. 3, 2026), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (Jan. 21, 2026).